Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals |
| |
Authors: | Vogel Martin Nattermann Jacob Baumgarten Axel Klausen Gerd Bieniek Bernhard Schewe Knud Jessen Heiko Boesecke Christoph Rausch Michael Lutz Thomas Fenske Stefan Schranzo Dietmar Kümmerle Tim Schuler Christoph Theisen Albert Mayr Christoph Seidel Thomas Rockstroh Jürgen K |
| |
Institution: | Department of Medicine I, University of Bonn, Germany. |
| |
Abstract: | BACKGROUND: Sexually transmitted acute hepatitis C among HIV-positive homosexual men has been noted as an emerging epidemic. METHODS: Forty-seven patients with mainly sexually acquired, acute hepatitis C were enrolled in this prospective, multicentre trial, and 36 of these patients were treated within the acute phase of hepatitis C infection with pegylated interferon (peg-IFN) therapy. RESULTS: Early treatment resulted in sustained virological response in 61% of patients. Peg-IFN alone showed similar treatment response rates and lower incidence of anaemia compared with peg-IFN+ribavirin combination therapy. Higher treatment response rates were observed in patients treated over 48 weeks compared with 24 weeks. CONCLUSIONS: Treatment of hepatitis C in HIV-positive individuals in the acute phase of infection leads to high rates of sustained virological response. Optimal time and mode of therapy have yet to be defined. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |